Your browser doesn't support javascript.
loading
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
McCreary, Erin K; Bariola, J Ryan; Wadas, Richard J; Shovel, Judith A; Wisniewski, Mary Kay; Adam, Michelle; Albin, Debbie; Minnier, Tami; Schmidhofer, Mark; Meyers, Russell; Marroquin, Oscar C; Collins, Kevin; Garrard, William; Berry, Lindsay R; Berry, Scott; Crawford, Amy M; McGlothlin, Anna; Linstrum, Kelsey; Nakayama, Anna; Montgomery, Stephanie K; Snyder, Graham M; Yealy, Donald M; Angus, Derek C; Kip, Paula L; Seymour, Christopher W; Huang, David T; Kip, Kevin E.
Afiliación
  • McCreary EK; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Bariola JR; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Wadas RJ; Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Shovel JA; Wolff Center, University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania.
  • Wisniewski MK; Wolff Center, University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania.
  • Adam M; Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Albin D; Supply Chain Management/HC Pharmacy, UPMC, Pittsburgh, Pennsylvania.
  • Minnier T; Wolff Center, University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania.
  • Schmidhofer M; Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Meyers R; Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Marroquin OC; Clinical Analytics, UPMC, Pittsburgh, Pennsylvania.
  • Collins K; Clinical Analytics, UPMC, Pittsburgh, Pennsylvania.
  • Garrard W; Clinical Analytics, UPMC, Pittsburgh, Pennsylvania.
  • Berry LR; Berry Consultants, Austin, Texas.
  • Berry S; Berry Consultants, Austin, Texas.
  • Crawford AM; Berry Consultants, Austin, Texas.
  • McGlothlin A; Berry Consultants, Austin, Texas.
  • Linstrum K; Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania.
  • Nakayama A; Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania.
  • Montgomery SK; Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania.
  • Snyder GM; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Yealy DM; Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Angus DC; Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania.
  • Kip PL; Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Seymour CW; Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania.
  • Huang DT; Office of Healthcare Innovation, UPMC, Pittsburgh, Pennsylvania.
  • Kip KE; Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
JAMA Netw Open ; 5(4): e226920, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35412625
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos